USPTO Examiner WINSTON III EDWARD B - Art Unit 3683

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18763966Aligning Image Data of a Patient with Actual Views of the Patient Using an Optical Code Affixed to the PatientJuly 2024February 2025Allow800YesNo
18635048CLINICAL RISK PREDICTION SYSTEM ORIENTED TO DATA DISTRIBUTION DRIFT DETECTION AND SELF-ADAPTATIONApril 2024September 2025Abandon1720NoNo
18681176METHOD AND SERVER FOR GENERATING, ON BASIS OF LANGUAGE MODEL, QUESTIONS OF PERSONALITY APTITUDE TEST BY USING QUESTION AND ANSWER NETWORKFebruary 2024December 2025Abandon2210NoNo
18426250ADVISING DIABETES MEDICATIONSJanuary 2024October 2024Allow800YesNo
18453759SYSTEM AND METHOD FOR MEASURING THE TREATMENT EFFECT OF A DRUGAugust 2023November 2025Abandon2720YesNo
18230973COMPUTER GRAPHICAL INTERFACE PROCESSING WITH REMOTE COMPUTING DEVICESAugust 2023March 2026Abandon3110NoNo
18364563MEDICAL INFORMATION PROCESSING APPARATUS, MEDICAL INFORMATION PROCESSING METHOD, AND STORAGE MEDIUMAugust 2023December 2025Abandon2910NoNo
18221867SYSTEM FOR MEDICAL TREATMENT RECOMMENDATION AND PREDICTIVE MODEL THEREOFJuly 2023November 2025Abandon2810NoNo
18039609REHABILITATION APPROACH PROPOSAL APPARATUS, REHABILITATION APPROACH PROPOSAL METHOD, AND NON-TRANSITORY COMPUTER-READABLE MEDIUMMay 2023September 2025Abandon2810NoNo
18140235MONITORING PATIENT DATAApril 2023January 2026Abandon3310NoNo
18032487SYSTEM, ELECTRONIC DEVICE, METHOD, AND PROGRAM FOR ADJUSTING INTAKE OF DRUGApril 2023September 2025Abandon2910NoNo
18181733SYSTEMS AND METHODS FOR PROVENANCE AND DATA INTEGRITY MONITORINGMarch 2023December 2025Abandon3320YesNo
18116980AVAILABILITY INDEX FOR CONNECTING WITH A USER VIA A NETWORK DEVICEMarch 2023December 2025Abandon3420NoNo
18091086APPARATUS FOR PREVENTING DECLINE OF LONGEVITYDecember 2022September 2024Abandon2170YesNo
17684872METHOD OF MAPPING PATIENT-HEALTHCARE ENCOUNTERS AND TRAINING MACHINE LEARNING MODELSMarch 2022November 2025Abandon4520NoNo
17673095SYSTEM FOR REALIZING REMOTE MONITORING OF MOVEMENT HEALTH OF PETFebruary 2022April 2025Abandon3810NoNo
17671992ELECTRONIC DEVICE AND OPERATION METHOD OF ELECTRONIC DEVICEFebruary 2022September 2025Abandon4330NoNo
17672318INSTRUCTION DOCUMENT CREATING SYSTEMFebruary 2022January 2026Abandon4740NoYes
17666787Medical Intelligence System and MethodFebruary 2022April 2025Abandon3820NoNo
17591083DIAGNOSIS ASSISTANCE APPARATUS AND DIAGNOSIS ASSISTANCE SYSTEMFebruary 2022February 2026Abandon4840YesNo
17614265A METHOD OF TREATMENT OR PROPHYLAXISNovember 2021October 2025Allow4620NoYes
17514091INFORMATION PROCESSING APPARATUS AND METHODOctober 2021January 2025Abandon3920NoNo
17428619METHOD FOR DATA PROCESSING TO DERIVE NEW DRUG CANDIDATE SUBSTANCEAugust 2021September 2025Abandon4920YesYes
17417406AUTOMATED DETECTION OF LUNG CONDITIONS FOR MONITORING THORACIC PATIENTS UNDERTGOING EXTERNAL BEAM RADIATION THERAPYJune 2021November 2025Allow5340YesNo
17350533PREDICTIVE METABOLIC INTERVENTIONJune 2021September 2025Abandon5150YesNo
17342517METHOD FOR DETERMINING TRAINING STATUS SELECTED FROM A SET OF TRAINING STATUS ALTERNATIVESJune 2021December 2025Abandon5420NoNo
17224110SYSTEM AND METHOD FOR AUTOMATED HEALTH AND FITNESS ADVISEMENTApril 2021April 2025Abandon4830YesNo
17217008SYSTEMS AND METHODS OF INTEGRATING MEDICAL DEVICE CASE FILES WITH CORRESPONDING PATIENT CARE RECORDSMarch 2021February 2026Allow5960YesNo
17189820Techniques For Delivering Real-Time Point Of Care Messaging To Health Care ProvidersMarch 2021January 2026Abandon5840YesYes
17132189SYSTEMS AND METHODS FOR NETWORK MONITORING IN REMOTE THERAPY SYSTEMSDecember 2020November 2024Abandon4640NoNo
17015092MEDICAL EXAMINATION MANAGEMENT DEVICE, MEDICAL EXAMINATION MANAGEMENT METHOD, AND PROGRAMSeptember 2020June 2025Abandon5840NoNo
16772534DIGITAL HEALTH PROXY SYSTEM AND DEVICEJune 2020June 2025Abandon6060YesNo
16827218ENHANCED PRESCRIPTION MANAGEMENT SYSTEMMarch 2020March 2025Abandon6040YesYes
16300279METHOD, COMMUNICATION SYSTEM AND COMPUTER PROGRAM FOR PROVIDING INFORMATION INDICATIVE OF CONCENTRATION OF ALLERGENS IN THE ENVIRONMENTNovember 2018June 2025Abandon6080YesNo
16177314ENHANCED PRESCRIPTION MANAGEMENT SYSTEMOctober 2018November 2025Abandon6080YesYes
15951463EXPEDITED ADMISSIONS AND MEDICATION DELIVERYApril 2018March 2025Abandon6060YesYes
15784144SECURE DATABASE SYSTEMS AND METHODS FOR DELIVERING HEALTH CARE TREATMENTOctober 2017December 2024Abandon6080NoNo
14748815Systems, Methods and Computer Program Products for Reducing the Risk of Persons Housed Within a Facility Being Sexual Predators or VictimsJune 2015September 2019Allow5120YesYes
14538802SYSTEMS AND METHODS FOR A MEDICAL CODER MARKETPLACENovember 2014May 2025Abandon60130YesNo
12365151NAVIGATION SYSTEM WITH PATH PREDICTION AND METHOD OF OPERATION THEREOFFebruary 2009September 2015Allow6020NoYes
12347371METHOD AND APPARATUS FOR PROVIDING MAPPING DATADecember 2008September 2015Allow6060YesNo
11936018METHODS FOR DEVELOPING AND CONDUCTING A NUTRITIONAL TREATMENT PROGRAMNovember 2007April 2010Allow3010YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WINSTON III, EDWARD B.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
4
Examiner Affirmed
3
(75.0%)
Examiner Reversed
1
(25.0%)
Reversal Percentile
41.3%
Lower than average

What This Means

With a 25.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
8
Allowed After Appeal Filing
3
(37.5%)
Not Allowed After Appeal Filing
5
(62.5%)
Filing Benefit Percentile
62.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 37.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner WINSTON III, EDWARD B - Prosecution Strategy Guide

Executive Summary

Examiner WINSTON III, EDWARD B works in Art Unit 3683 and has examined 22 patent applications in our dataset. With an allowance rate of 31.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 58 months.

Allowance Patterns

Examiner WINSTON III, EDWARD B's allowance rate of 31.8% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by WINSTON III, EDWARD B receive 4.64 office actions before reaching final disposition. This places the examiner in the 99% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by WINSTON III, EDWARD B is 58 months. This places the examiner in the 1% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +4.8% benefit to allowance rate for applications examined by WINSTON III, EDWARD B. This interview benefit is in the 29% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 4.4% of applications are subsequently allowed. This success rate is in the 2% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 12.5% of cases where such amendments are filed. This entry rate is in the 13% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 20% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 42.9% of appeals filed. This is in the 9% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 7% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 4.5% of allowed cases (in the 85% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.